AIMS: To characterise the disease in patients with mutations in RPE65. METHODS: Individuals from two families were studied clinically. RESULTS: 13 and 20 year old compound heterozygote individuals from one family with R234X and 1121delA mutations showed nystagmus, macular dystrophy and low contrasted spots in the fundus. Some heterozygotes had macular drusen. A 40 year old compound heterozygote individual from another family with L22P and H68Y mutations had few bone spicule pigment deposits and macular atrophy. CONCLUSION: Compound heterozygote individuals had severe rod-cone dystrophies featuring few pigment deposits in the fundus, pigment epithelium atrophy, and early involvement of the macula, with variations in severity leading to the diagnosis of Leber's congenital amaurosis or retinitis pigmentosa. Macular drusen in heterozygotes carrying a null allele may reflect the decreased capacity in the RPE65 function.
AIMS: To characterise the disease in patients with mutations in RPE65. METHODS: Individuals from two families were studied clinically. RESULTS: 13 and 20 year old compound heterozygote individuals from one family with R234X and 1121delA mutations showed nystagmus, macular dystrophy and low contrasted spots in the fundus. Some heterozygotes had macular drusen. A 40 year old compound heterozygote individual from another family with L22P and H68Y mutations had few bone spicule pigment deposits and macular atrophy. CONCLUSION: Compound heterozygote individuals had severe rod-cone dystrophies featuring few pigment deposits in the fundus, pigment epithelium atrophy, and early involvement of the macula, with variations in severity leading to the diagnosis of Leber's congenital amaurosis or retinitis pigmentosa. Macular drusen in heterozygotes carrying a null allele may reflect the decreased capacity in the RPE65 function.
Authors: S M Gu; D A Thompson; C R Srikumari; B Lorenz; U Finckh; A Nicoletti; K R Murthy; M Rathmann; G Kumaramanickavel; M J Denton; A Gal Journal: Nat Genet Date: 1997-10 Impact factor: 38.330
Authors: F Marlhens; C Bareil; J M Griffoin; E Zrenner; P Amalric; C Eliaou; S Y Liu; E Harris; T M Redmond; B Arnaud; M Claustres; C P Hamel Journal: Nat Genet Date: 1997-10 Impact factor: 38.330
Authors: C A Lewis; I R Batlle; K G Batlle; P Banerjee; A V Cideciyan; J Huang; T S Alemán; Y Huang; J Ott; T C Gilliam; J A Knowles; S G Jacobson Journal: Invest Ophthalmol Vis Sci Date: 1999-08 Impact factor: 4.799
Authors: H Morimura; G A Fishman; S A Grover; A B Fulton; E L Berson; T P Dryja Journal: Proc Natl Acad Sci U S A Date: 1998-03-17 Impact factor: 11.205
Authors: A J Lotery; P Namperumalsamy; S G Jacobson; R G Weleber; G A Fishman; M A Musarella; C S Hoyt; E Héon; A Levin; J Jan; B Lam; R E Carr; A Franklin; S Radha; J L Andorf; V C Sheffield; E M Stone Journal: Arch Ophthalmol Date: 2000-04
Authors: T M Redmond; S Yu; E Lee; D Bok; D Hamasaki; N Chen; P Goletz; J X Ma; R K Crouch; K Pfeifer Journal: Nat Genet Date: 1998-12 Impact factor: 38.330
Authors: Leila El Matri; Aude Ambresin; Daniel F Schorderet; Aki Kawasaki; Mathias W Seeliger; Andreas Wenzel; Yvan Arsenijevic; François-Xavier Borruat; Francis L Munier Journal: Graefes Arch Clin Exp Ophthalmol Date: 2006-02-28 Impact factor: 3.117
Authors: Birgit Lorenz; Eugenia Poliakov; Maria Schambeck; Christoph Friedburg; Markus N Preising; T Michael Redmond Journal: Invest Ophthalmol Vis Sci Date: 2008-07-03 Impact factor: 4.799
Authors: Samuel G Jacobson; Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Sharon B Schwartz; Elizabeth A M Windsor; Elias I Traboulsi; Elise Heon; Steven J Pittler; Ann H Milam; Albert M Maguire; Krzysztof Palczewski; Edwin M Stone; Jean Bennett Journal: Proc Natl Acad Sci U S A Date: 2005-04-18 Impact factor: 11.205
Authors: Dennis M Maddox; Wanda L Hicks; Douglas Vollrath; Matthew M LaVail; Jürgen K Naggert; Patsy M Nishina Journal: Invest Ophthalmol Vis Sci Date: 2011-07-01 Impact factor: 4.799